Patent · US Active

Methods of using variants of FGF19 polypeptides for the treatment of cancer

US10369199B2 · kind B2 · utility

9Cited by
69References
25Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 27, 2014
Grant dateAug 6, 2019
Priority date
Expiry dateJan 8, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7066
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided are methods of antagonizing the oncogenic activity of FGF19 in a subject. Also provided are methods of treating a FGF19-dependent cancer or tumor, or a symptom thereof in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.